Sopharma AD-Sofia (WAR:SPH) Cyclically Adjusted PB Ratio: (As of Aug. 31, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:SPH Sopharma AD-Sofia WAR:SPH
67 GF Score
Price zł8.10
GF Value zł13.12
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Sopharma AD-Sofia Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Sopharma AD-Sofia  (WAR:SPH) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Sopharma AD-Sofia Cyclically Adjusted PB Ratio Related Terms


Sopharma AD-Sofia Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Sopharma AD-Sofia's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sopharma AD-Sofia Cyclically Adjusted PB Ratio Chart

Sopharma AD-Sofia Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.18 1.96 2.34 2.25 1.07

Sopharma AD-Sofia Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.71 1.03 1.07 0.67 0.00

WAR:SPH vs MCK, COR, CAH: Cyclically Adjusted PB Ratio Comparison

For the Medical Distribution subindustry, Sopharma AD-Sofia's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sopharma AD-Sofia Cyclically Adjusted PB Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sopharma AD-Sofia's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Sopharma AD-Sofia's Cyclically Adjusted PB Ratio falls into.


WAR:SPH
67GF Score
Sopharma AD-Sofia WAR:SPH
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sopharma AD-Sofia Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Sopharma AD-Sofia's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Sopharma AD-Sofia's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=4.136/333.9520*333.9520
=4.136

Current CPI (Jun. 2026) = 333.9520.

Sopharma AD-Sofia Quarterly Data

Book Value per Share CPI Adj_Book
201606 6.978 241.018 9.669
201609 7.065 241.428 9.773
201612 7.172 241.432 9.920
201703 7.463 243.801 10.223
201706 7.827 244.955 10.671
201709 8.434 246.819 11.411
201712 8.396 246.524 11.374
201803 8.952 249.554 11.980
201806 8.360 251.989 11.079
201809 8.369 252.439 11.071
201812 8.156 251.233 10.841
201903 8.411 254.202 11.050
201906 8.515 256.143 11.102
201909 8.495 256.759 11.049
201912 9.336 256.974 12.133
202006 9.633 257.797 12.479
202009 9.981 260.280 12.806
202012 10.157 260.474 13.022
202103 0.000 264.877 0.000
202106 10.620 271.696 13.053
202109 10.834 274.310 13.190
202112 11.399 278.802 13.654
202203 11.444 287.504 13.293
202206 11.360 296.311 12.803
202209 10.990 296.808 12.365
202212 11.615 296.797 13.069
202303 12.330 301.836 13.642
202306 11.815 305.109 12.932
202309 11.949 307.789 12.965
202312 9.644 306.746 10.499
202403 10.371 312.332 11.089
202406 9.887 314.175 10.509
202409 10.375 315.301 10.989
202412 9.808 315.605 10.378
202503 10.638 319.799 11.109
202506 11.475 322.561 11.880
202509 4.087 324.800 4.202
202512 4.003 324.054 4.125
202603 4.259 330.213 4.307
202606 4.136 333.952 4.136

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Sopharma AD-Sofia (WAR:SPH) Overvalued in 2026?

Based on GuruFocus' analysis, Sopharma AD-Sofia stock appears to be undervalued. The current stock price of zł8.10 is trading 38.3% below its estimated GF Value™ of zł13.12. GuruFocus considers Sopharma AD-Sofia to be Possible Value Trap.

Key valuation signals for WAR:SPH:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: zł13.12 vs. price of zł8.10 (38.3% below fair value)
  • GF Score™: 67/100 with 4 warning signs

No single metric tells the full story. See the WAR:SPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sopharma AD-Sofia Business Description

Other Exchanges 3JR:GermanySFA:Bulgaria
Address 5 Lachezar Stanchev Street, Sopharma Business Towers, Building A, Floor 12, Sofia, BGR, 1756
Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are the Production of pharmaceutical products; Distribution of pharmaceutical products. It generates the majority of its revenue from the Distribution of pharmaceutical products.
67GF Score

Get the complete analysis for WAR:SPH

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł8.10
Price
zł13.12
GF Value